From our innovative patented 311 technology, Unifarco Biomedical has developed Ceramol 311: not merely an emollient product, it also repairs the epidermal barrier.
311 describes the precise ratio between 3 key lipids of the epidermis: 3 parts ceramide, to 1 part cholesterol, to 1 part fatty acids.
Ceramol 311 harnesses the skin's own repairing mechanisms, returning it to a healthy state.
Find out more about Ceramol 311
www.unifarcobio...
5 сен 2024